Lack of Consensus for Margin Width Leads to Additional Breast Cancer Surgery

Share this content:

the Cancer Therapy Advisor take:

According to researchers from the University of Wisconsin School of Medicine and Public Health, the lack of consensus or established guidelines on the sufficient distance of excision between the tumor and the edge of surrounding tissue during breast cancer surgery has lead to variable excision rates and additional operations, by as much as 60%.

The authors of a study published recently in JAMA Surgery used the National Cancer database to analyze data from 316,114 patients who underwent breast cancer surgery in the United States between 2004 and 2010 (patients who were initially treated with chemotherapy or excision biopsy were excluded).

Seventy-six percent of these patients had a single lumpectomy, and of those patients, almost 24% had at least one additional operation for their breast cancer (62% with a completion lumpectomy; 38% with a complete mastectomy). It is hoped that the results from this analysis will help to inform patients about the risk for repeat surgery for breast cancer, and will also spur guidelines that will standardize tumor margin and help reduce local recurrence rates.

Additional breast cancer operations can cause the patient added distress, cost, and delays to adjuvant therapy, so avoiding these often unnecessary surgeries may ultimately improve patient outcome and prevent wasted health care resources.

High-Fat Diet Ups Risk for Certain Breast Cancers
Lack of consensus on distance of excision between tumor and tissue has lead to variable excision rates.
In their study, the authors suggest that a lack of consensus on sufficient margin width - the distance between the tumor and the edge of the surrounding tissue that is removed during surgery - leads to variable rates of re-excision and the possibility of repeat or additional operations.
READ FULL ARTICLE From Medical News Today

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs